Cadherin-3

Cadherin-3 Informations sur la molécule

Nom anglais	Cadherin 3	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	7	Alias de la cible	Cadherin 3， Type 1， P-Cadherin (Placental)，Placental Cadherin，CDHP，P-cadherin，CDH3，Cadherin 3，Calcium-Dependent Adhesion Protein， Placental，Cadherin 3， P-Cadherin (Placental)，Cadherin-3，HJMD，PCAD
Phase de R&D la plus avancée	Phase 2 Clinical

Nom anglais	Cadherin 3
Alias de la cible	Cadherin 3， Type 1， P-Cadherin (Placental)，Placental Cadherin，CDHP，P-cadherin，CDH3，Cadherin 3，Calcium-Dependent Adhesion Protein， Placental，Cadherin 3， P-Cadherin (Placental)，Cadherin-3，HJMD，PCAD
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	7
Phase de R&D la plus avancée	Phase 2 Clinical

Cadherin-3 Liste de produits

Attribut
Protein (3)
Bibliothèque de produits
En ligne (3)
Espèces
Human (1)Mouse (1)Cynomolgus (1)
Étiquette
His Tag (3)
Marqueur
Unconjugated (3)

Numéro de produit	Espèces	Système d'expression	Description du produit	Pré-commande/Commande
CA3-H52H3	Human	HEK293	Human Cadherin-3 Protein, His Tag, low endotoxin	Ajouter au panier
CA3-M52H3	Mouse	HEK293	Mouse Cadherin-3 Protein, His Tag	Ajouter au panier
CA3-C52H3	Cynomolgus	HEK293	Cynomolgus Cadherin-3 Protein, His Tag	Ajouter au panier

Quantité totale3

Cadherin-3Contexte de la molécule

Cadherin-3 （also known as P-cadherin）is a classical cell-to-cell adhesion molecule with a homeostatic function in several normal tissues. In humans, cadherin-3 is only detected in a few organs. However, its overexpression is strongly associated with a poor prognosis in some solid tumors including breast, lung and pancreatic cancers.

Cadherin-3Alias de la molécule

CDH3,CDHP,Cadherin-3,P-cadherin

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
STEMVAC	EP-101	Phase 2 Clinical	Epithany	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; HR-positive breast cancer; Lung Neoplasms; Triple Negative Breast Neoplasms	Details
BC-3195	BC3195; BC-3195	Phase 2 Clinical	Wuxi BioCity	Neoplasm Metastasis; Neoplasms; Solid tumours	Details
FF-21101-Y-90	FF-21101-Y-90; PPMX-T002	Phase 1 Clinical	Fujifilm Holdings Corp	Solid tumours	Details
FF-21101	FF-21101	Phase 1 Clinical	Perseus Proteomics Inc	Bile Duct Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours	Details
TRAILR2/CDH3 bispecific antibody (Boehringer Ingelheim)		Phase 1 Clinical	Boehringer Ingelheim International Gmbh	Neoplasms	Details
AMG 305	AMG 305; AMG-305	Phase 1 Clinical	Amgen Inc	Solid tumours	Details
FF-21101In	FF-21101In	Phase 1 Clinical	PeptiDream Inc	Solid tumours	Details